-+ 0.00%
-+ 0.00%
-+ 0.00%

Sobi Upgrades FY26 Revenue Growth Outlook

MT Newswires·07/16/2026 02:42:37
Listen to the news
02:42 AM EDT, 07/16/2026 (MT Newswires) -- Swedish Orphan Biovitrum (SOBI.ST), or Sobi, on Thursday upgraded its revenue growth guidance for 2026. The Swedish pharmaceuticals company now expects its topline to rise by a mid- to high-teens percentage at constant exchange rate, compared with its previous forecast of a low double-digit increase.